Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rockwell Medical Affirms FY2025 Sales Guidance of $65.00M-$70.00M vs $67.42M Est

Author: Benzinga Newsdesk | May 12, 2025 05:03am

GUIDANCE

Rockwell confirms its 2025 annual guidance as follows:

 2025 Annual Guidance
Net Sales$65.0M to $70.0M
Gross Margin16% to 18%
Adjusted EBITDA($0.5)M to $0.5M

Posted In: RMTI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist